[HTML][HTML] Ferroptosis and musculoskeletal diseases:“Iron Maiden” cell death may be a promising therapeutic target

Y Zhang, X Huang, B Qi, C Sun, K Sun, N Liu… - Frontiers in …, 2022 - frontiersin.org
… Therefore, therapeutic targets linking aging and disease may extend the healthy life span
of … /miR-10a-5p/IL-6R axis could be a potential therapeutic target for intervention in IVDD (114). …

[HTML][HTML] Myostatin inhibitors: panacea or predicament for musculoskeletal disorders?

J Suh, YS Lee - Journal of bone metabolism, 2020 - ncbi.nlm.nih.gov
therapeutic target for various musculoskeletal disorders. In fact, numerous myostatin-inhibiting
pharmacological agents have been developed, and many of them have progressed to …

Berberine and musculoskeletal disorders: the therapeutic potential and underlying molecular mechanisms

SK Wong, KY Chin, S Ima-Nirwana - Phytomedicine, 2020 - Elsevier
therapeutic potential of berberine and its mechanism of action in treating musculoskeletal
disorders. … There are a variety of treatment modalities for musculoskeletal disorders, including …

Novel insights into the interaction between N6‐methyladenosine methylation and noncoding RNAs in musculoskeletal disorders

J Han, H Kong, X Wang, X Zhang - Cell Proliferation, 2022 - Wiley Online Library
… found abnormally expressed in musculoskeletal diseases and participate in … therapeutic
targets for diseases. In IDD, hucMSCs deliver exogenous miR-26a-5p, which can directly target

Current advances and novel research on minimal invasive techniques for musculoskeletal disorders

C Romero-Morales, M Bravo-Aguilar, V Abuin-Porras… - Disease-a-Month, 2021 - Elsevier
… physical therapy applications in musculoskeletal disorders of … , and multiple soreness location
disorders, such as fibromyalgia. … As an increasing technique in physical therapy, the use of …

[HTML][HTML] Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders

W Zhang, L He, Z Liu, X Ren, L Qi, L Wan… - Frontiers in Cell and …, 2020 - frontiersin.org
… of musculoskeletal diseases. In this review, we broadly summarize the functional repertoire
of m 6 A in various musculoskeletal disorderstherapeutic target in musculoskeletal diseases. …

Targeting neurotrophic factors: novel approaches to musculoskeletal pain

AM Malfait, RE Miller, JA Block - Pharmacology & therapeutics, 2020 - Elsevier
… advanced in the area of musculoskeletal pain. This narrative review discusses the neurotrophic
factors that appear to hold the greatest promise as therapeutic targets in the near future, …

[HTML][HTML] Role of matrix metalloproteinases in musculoskeletal diseases

L Kumar, M Bisen, A Khan, P Kumar, SKS Patel - Biomedicines, 2022 - mdpi.com
… the function of MMPs as a therapeutic target for musculoskeletal disorders [77], including …
This necessitates a comprehensive examination to design targeted therapeutic interventions…

Advanced glycation end products in musculoskeletal system and disorders

A Suzuki, A Yabu, H Nakamura - Methods, 2022 - Elsevier
… patients often have musculoskeletal disorder, which are … the prevention and therapy of such
disorders which affect patients’ … which AGEs cause or exacerbate musculoskeletal disorders. …

[HTML][HTML] An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic …

YJ Yang, DJ Kim - International journal of molecular sciences, 2021 - mdpi.com
… of the molecular mechanisms of musculoskeletal disorders accompanying the …
musculoskeletal disorders would be contributes to the development of effective therapies targeting